New study explores psychedelic therapy for co-occurring cocaine addiction and depression

by rss feed | Oct 22, 2026 | News Feeds

A team of UTHealth Houston researchers has been awarded a five-year, $3.4 million grant to study whether psilocybin-assisted therapy is a viable treatment option for individuals with co-occurring cocaine use disorder and major depressive disorder. Read Original...

INmune Bio establishes global commercialization framework for Ebstrocel™ through strategic agreement with Uniphar

by rss feed | Oct 22, 2026 | News Feeds

INmune Bio Inc. (the “Company”), a late-stage biotechnology company focused on inflammation and immunology, today announced that it has entered into a Master Services Agreement with Uniphar Durbin Ireland Limited (“Uniphar”) establishing a scalable framework to...

New national trial platform aims to accelerate Alzheimer’s disease prevention

by rss feed | Oct 22, 2026 | News Feeds

Researchers from the University of California San Diego will join a collaboration as part of a federal award of up to $41 million to launch a national effort aimed at accelerating the search for treatments that could prevent or slow Alzheimer's disease. Read Original...

Stem cell therapies may need new protein quality control standards

by rss feed | Oct 22, 2026 | News Feeds

Current Good Manufacturing Practice (GMP) standards for cell therapies assess identity, viability, sterility, and genetic stability. For extracellular vesicle (EV) products, Minimal Information for Studies of Extracellular Vesicles (MISEV2023) guidance adds particle...

Review offers guidance for managing recurrent catheter-related bloodstream infections

by rss feed | Oct 22, 2026 | News Feeds

Patients who depend on long-term intravenous catheters for chemotherapy, hemodialysis, intravenous nutrition and other essential therapies face an ongoing risk of catheter-related bloodstream infections, a potentially life-threatening complication that can be...